The publication of modern slavery statements (statements) on this Register does not indicate compliance with the requirements of the Modern Slavery Act 2018 (the Act). Pursuant to section 19(2) of the Act, the Attorney-General’s Department publishes all statements properly submitted to this Register, including compliant and non-compliant statements, in order to maximise transparency and ensure entities are publicly accountable for their actions to address modern slavery risks. Statements that fail to meet the requirements for approval and signature set out in sections 13(2) or 14(2) of the Act will not be registered.

Number
2023-1405
Type
Single
Period
01 January 2022 to 31 December 2022
Annual revenue
450-500M
Industry sectors
Healthcare and pharmaceuticals
Countries
Denmark
Key brands and business names
Ozempic, Wegovy, Saxenda, Norditropin, Ryzodeg, Glycogen, Novo 7, Novo 13, Vagifem
Reporting Obligations
NSW Modern Slavery Act 2018
Date submitted
30/06/2023
Date published
28/07/2023